Evidence map›Paper›PMID 33446797›Full record

ArticleScientific reports2021

S100A8/A9 mediate the reprograming of normal mammary epithelial cells induced by dynamic cell-cell interactions with adjacent breast cancer cells.

Seol Hwa Jo, Woo Hang Heo, Hye-Youn Son, Mingji Quan, Bok Sil Hong, Ju Hee Kim, Han-Byoel Lee, Wonshik Han, Yeonju Park, Dong-Sup Lee and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. CD45Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2023
    Article
  7. Post-translational modifications on the metal-sequestering protein calprotectin.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Seol Hwa Jo *Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
Woo Hang Heo *Interdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
Hye-Youn Son *Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Mingji QuanInterdisciplinary Graduate Program in Cancer Biology, Seoul National University College of Medicine, Seoul, Korea.
Bok Sil HongCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Ju Hee KimCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Han-Byoel LeeCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Wonshik HanCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Yeonju ParkDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
Dong-Sup LeeDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
Nam Hoon KwonMedicinal Bioconvergence Research Center, Seoul National University, Suwon, Korea.
Min Chul ParkMedicinal Bioconvergence Research Center, Seoul National University, Suwon, Korea.
Jeesoo ChaeMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea.
Jong-Il KimMedical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea.
Dong-Young NohCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
Hyeong-Gon MoonCenter for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. moonhg74@snu.ac.kr.
Seoul National University · KRSeoul National University Hospital · KR

Funding

Korea Health Industry Development Institute HA15C0011National Research Foundation of Korea NRF-2019R1A2C2005277National Research Foundation of Korea NRF-2019R1C1C1006898
6 · The paper itself

Abstract

To understand the potential effects of cancer cells on surrounding normal mammary epithelial cells, we performed direct co-culture of non-tumorigenic mammary epithelial MCF10A cells and various breast cancer cells. Firstly, we observed dynamic cell-cell interactions between the MCF10A cells and breast cancer cells including lamellipodia or nanotube-like contacts and transfer of extracellular vesicles. Co-cultured MCF10A cells exhibited features of epithelial-mesenchymal transition, and showed increased capacity of cell proliferation, migration, colony formation, and 3-dimensional sphere formation. Direct co-culture showed most distinct phenotype changes in MCF10A cells followed by conditioned media treatment and indirect co-culture. Transcriptome analysis and phosphor-protein array suggested that several cancer-related pathways are significantly dysregulated in MCF10A cells after the direct co-culture with breast cancer cells. S100A8 and S100A9 showed distinct up-regulation in the co-cultured MCF10A cells and their microenvironmental upregulation was also observed in the orthotropic xenograft of syngeneic mouse mammary tumors. When S100A8/A9 overexpression was induced in MCF10A cells, the cells showed phenotypic features of directly co-cultured MCF10A cells in terms of in vitro cell behaviors and signaling activities suggesting a S100A8/A9-mediated transition program in non-tumorigenic epithelial cells. This study suggests the possibility of dynamic cell-cell interactions between non-tumorigenic mammary epithelial cells and breast cancer cells that could lead to a substantial transition in molecular and functional characteristics of mammary epithelial cells.

Indexed as

Cell CommunicationAnimalsBreast NeoplasmsCalgranulin ACalgranulin BCell Line, TumorEpithelial CellsFemaleHumansMammary Glands, HumanMiceMice, Inbred BALB CNeoplasm ProteinsCalgranulin ACalgranulin BNeoplasm ProteinsS100A8 protein, humanS100A9 protein, human

Identifiers

PMID33446797
PMCPMC7809201
OpenAlexW3123947496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.